3 competitive national public projects led: ISCIII and MICINN
1 private project led
6 clinical studies led
1 competitive HR contract
10 publications
IF: 218.92
Q1 publications: 5 (50%)
D1 publications: 3(30%)
1 thesis
Project evaluator in national associations: 1 PI
Member of editorial committees: 1 PI
Milestones
Granting of two research projects from the National Plan funded by the ISCIII (AES 2023): PI23/01302 IP. Dr. María Álvarez and PI23/01819 IP. Dr. Mª Jesús del Cerro.
Start of the competitive national research project: "Brain endophenotypes, genetic and epigenetic effects in transgender adolescents, before and after treatment with puberty blockers" (Ministry of Science in Innovation) Dr. Beatriz García Cuartero, IP at our Institution.
Recruitment and observation of patients in clinical trial: "Open study to evaluate the pharmacokinetics, pharmacodynamics and safety of bempedoic acid in pediatric patients (6 to 17 years) with heterozygous familial hypercholesterolemia" led by Dr. García Cuartero.
From 2024 we will have a new Principal Investigator in the group, Dr. María Álvarez Fuentes.
Participation in the first European guidelines on the multidisciplinary management of liver disease associated with Fontan circulation. (Téllez, L. et al. EASL-ERN position paper on liver involvement in patients with Fontan-type circulation. J Hepatol. 2023 Nov;79(5):1270-1301. DOI: 10.1016/j.jhep.2023.07.013. PMID: 37863545)
